A case report on anesthetic challenges in the post-Covid complication of active mucormycosis: Patient preparedness for family physicians.

关于活动性毛霉菌病后 Covid 并发症中麻醉挑战的病例报告 ： 家庭医生的患者准备。

• 发表时间: Jul 2022
• 来源期刊: J Family Med Prim Care
• DOI: 10.4103/jfmpc.jfmpc_2428_21
• PMID: 36387678
• 文章类型: Case Reports
• 作者列表: Uppalapati VK,Ranjan R,Singh UK,Kumar H,Shukla R

关键词: Anticipated difficult airway; drug interactions; general anesthesia; intravenous amphotericin B (AmB); mucormycosis; post-Covid pneumonia; video laryngoscope

Abstract

Mucormycosis is a well-known yet complicated illness that seems benign but behaves malignantly. This article discusses the anesthesia challenges in providing care for a 49-year-old male who presented with post-Covid pneumonia and uncontrolled diabetes along with active mucormycosis and scheduled for functional endoscope sinus surgery (FESS) and debridement of necrotic tissue. We want to illustrate the importance of anticipated difficult airway, while highlighting the toxicity of intravenous amphotericin-B and its combination against anesthesia drugs.

摘要

毛霉菌病是一种众所周知但复杂的疾病，看起来是良性的，但表现为恶性。本文讨论了为一名49岁男性提供护理的麻醉挑战，该男性患有Covid后肺炎和未控制的糖尿病，伴有活动性毛霉菌病，并计划进行功能性内窥镜鼻窦手术（FESS）和坏死组织清创。我们想说明预期的困难气道的重要性，同时强调了静脉注射两性霉素B及其组合对麻醉药物的毒性。